Dr Reddy�s Laboratories, the Indian Partner of Russian Direct Investment Fund (RDVIF), informed that it has commenced Sputnik-V�s India rollout with the first dose being administered in Hyderabad on Friday (Today, 13th May)as part of a limited pilot!
The company also informed that the imported vaccine has been priced at Rs. 948/- per dose with an additional GST of 5% to be charged on it, putting the price around at Rs. 995.40, just under Rs. 1000/- a dose!
In a regulatory filing with the bourses, the company further informed: �As part of a limited pilot, the soft launch of the vaccine has commenced and the 1st dose of the vaccine was administered in Hyderabad today (Friday, 14th May)�.
It said, �The imported doses of the vaccine are presently priced at an MRP of Rs. 948 + GST@5% per dose, with the possibility of a lower price point when local supply begins!�
The company said that the 1st consignment of imported doses of the Sputnik-V Vaccine, that landed in India on 1st May 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on 13th May 2021.
According to Dr Reddy�s, further consignments of imported doses are expected over the upcoming months and subsequently, supply of the Sputnik-V Vaccine will commence from Indian manufacturing partners.
The comp[any further informed: �The Company has been working closely with its manufacturing partners in India to fulfil regulatory requirements to ensure smooth and timely supply. Dr Reddy�s will closely work with the stakeholders in the government and private sector in India to ensure the widest possible reach of the Sputnik-V Vaccines as a part of the national inoculation effort!�
Dr Reddy�s Co-Chairman and Managing Director G V Prasad said: �With the rising cases in India, vaccination is the most effective tool in our battle against Covid-19. Contributing to the vaccination drive-in India is our biggest priority right now to help Indians be healthy and safe!�